Chiropractors in Egg Harbor Township, NJ Accepting Medicare
8 Chiropractors found. Showing 1 - 8
 Dibartolo Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 4036 Ocean Heights Ave, Egg Harbor Township, NJ 08234 Phone: 609-926-1100 Fax: 609-926-0054 |
Casey Klingert Dc Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1319 Old Zion Rd, Egg Harbor Township, NJ 08234 Phone: 609-653-1100 |
Living Well Holistic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 6314 Black Horse Pike, Suite B, Egg Harbor Township, NJ 08234 Phone: 609-484-8333 Fax: 609-484-8019 |
 Dr. Holly Rita Zimmermann, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 6106 Black Horse Pike Ste A3, Egg Harbor Township, NJ 08234 Phone: 609-415-2821 |
Klingert Family Chiropractic Center P C Chiropractor Medicare: Medicare Enrolled Practice Location: 1319 Old Zion Rd, Egg Harbor Township, NJ 08234 Phone: 609-653-1100 Fax: 609-653-1820 |
 Dr. Casey Joseph Klingert, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1319 Old Zion Rd, Egg Harbor Township, NJ 08234 Phone: 609-653-1100 |
Dr. Nipur Desai, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2102 Ocean Heights Ave, Egg Harbor Township, NJ 08234 Phone: 609-653-6624 Fax: 609-653-4453 |
Dr. Richard Michael Klingert, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1319 Old Zion Rd, Egg Harbor Township, NJ 08234 Phone: 609-653-1100 Fax: 609-653-1820 |
News Archive
University of Birmingham researchers receive £1.5 million to find new treatments for bowel cancer
Charity Cancer Research UK has awarded the University of Birmingham £1.5 million to fund a five-year research program aimed at finding new treatments for bowel cancer.
Scientists discover process by which mda-9/syntenin contributes to melanoma metastasis
After recently announcing success in eliminating melanoma metastasis in laboratory experiments, scientists at Virginia Commonwealth University Massey Cancer Center have made another important discovery in understanding the process by which the gene mda-9/syntenin contributes to metastasis in melanoma (the spread of skin cancer) and possibly a variety of other cancers.
Roche's new breast cancer drug Pertuzumab up for FDA review
U.S. health regulators, the Food and Drugs Administration (FDA) has granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. Pertuzumab approval decision is due by June 8th this year. It could be used with Herceptin in HER2-positive patients. This was announced by Roche Holding AG's Genentech unit on Tuesday.
Recombinant hormone could REPLACE calcium supplements
Results from the phase III REPLACE trial of recombinant human parathyroid hormone (rhPTH) indicate the treatment can successfully combat the underlying deficit in hypoparathyroidism.
› Verified 1 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Occupational Therapists
Optometrists
Podiatrists
Audiologists